NDC 71610-827 – Lorazepam

Lorazepam .5 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CIV

Product NDC71610-827

Product details

Brand name
Lorazepam
Generic name
Lorazepam
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA076045
Marketed since
October 26, 2023
Listing expires
December 31, 2026
Pharmacologic class
Benzodiazepine

Active ingredients

Uses, dosage, side effects and warnings for Lorazepam →

Package NDC codes (12)

Package NDCDescriptionSince
71610-827-1010 TABLET in 1 BOTTLE (71610-827-10)May 2, 2024
71610-827-1515 TABLET in 1 BOTTLE (71610-827-15)May 8, 2024
71610-827-2020 TABLET in 1 BOTTLE (71610-827-20)May 8, 2024
71610-827-2828 TABLET in 1 BOTTLE (71610-827-28)May 2, 2024
71610-827-3030 TABLET in 1 BOTTLE (71610-827-30)May 2, 2024
71610-827-4545 TABLET in 1 BOTTLE (71610-827-45)May 2, 2024
71610-827-5360 TABLET in 1 BOTTLE (71610-827-53)May 2, 2024
71610-827-6090 TABLET in 1 BOTTLE (71610-827-60)May 2, 2024
71610-827-70120 TABLET in 1 BOTTLE (71610-827-70)Jun 5, 2024
71610-827-75150 TABLET in 1 BOTTLE (71610-827-75)Apr 15, 2025
71610-827-80180 TABLET in 1 BOTTLE (71610-827-80)May 2, 2024
71610-827-92270 TABLET in 1 BOTTLE (71610-827-92)May 2, 2024

Other Lorazepam products